Jenna Davidner
Stock Analyst at Barclays
(1.12)
# 3,579
Out of 4,670 analysts
26
Total ratings
42.1%
Success rate
-2.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jenna Davidner
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XERS Xeris Biopharma Holdings | Maintained: Buy | $9 → $12 | $8.70 | +37.93% | 4 | Aug 20, 2026 | |
| COLL Collegium Pharmaceutical | Reiterated: Buy | $56 → $48 | $27.11 | +77.06% | 7 | Aug 18, 2026 | |
| PCRX Pacira BioSciences | Maintained: Hold | $25 | $24.67 | +1.34% | 5 | Aug 17, 2026 | |
| PHAT Phathom Pharmaceuticals | Maintained: Buy | $18 → $14 | $8.87 | +57.84% | 4 | Aug 17, 2026 | |
| TARS Tarsus Pharmaceuticals | Maintained: Buy | $100 | $72.70 | +37.55% | 6 | Jul 10, 2026 |
Xeris Biopharma Holdings
Aug 20, 2026
Maintained: Buy
Price Target: $9 → $12
Current: $8.70
Upside: +37.93%
Collegium Pharmaceutical
Aug 18, 2026
Reiterated: Buy
Price Target: $56 → $48
Current: $27.11
Upside: +77.06%
Pacira BioSciences
Aug 17, 2026
Maintained: Hold
Price Target: $25
Current: $24.67
Upside: +1.34%
Phathom Pharmaceuticals
Aug 17, 2026
Maintained: Buy
Price Target: $18 → $14
Current: $8.87
Upside: +57.84%
Tarsus Pharmaceuticals
Jul 10, 2026
Maintained: Buy
Price Target: $100
Current: $72.70
Upside: +37.55%